![Pyrazolo[1,5-A]pyrimidines for antiviral treatment](/docs/US/2018-05-01/US09957275B2/abs.jpg.600x600.jpg)
- 专利标题： Pyrazolo[1,5-A]pyrimidines for antiviral treatment
-
申请号： US15639970申请日： 2017-06-30
-
公开(公告)号： US09957275B2公开(公告)日： 2018-05-01
- 发明人: Kerim Babaoglu , Constantine G. Boojamra , Eugene J. Eisenberg , Hon Chung Hui , Richard L. Mackman , Jay P. Parrish , Michael Sangi , Oliver L. Saunders , Dustin Siegel , David Sperandio , Hai Yang
- 申请人： Gilead Sciences, Inc.
- 申请人地址： US CA Foster City
- 专利权人： Gilead Sciences, Inc.
- 当前专利权人： Gilead Sciences, Inc.
- 当前专利权人地址： US CA Foster City
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D487/08 ; C07D495/04 ; C07D513/04 ; A61K31/519 ; A61K45/06 ; A61K31/5377 ; A61K31/55 ; A61K31/551 ; A61K31/675 ; C07F9/6561 ; C07D519/00
![Pyrazolo[1,5-A]pyrimidines for antiviral treatment](/abs-image/US/2018/05/01/US09957275B2/abs.jpg.150x150.jpg)
摘要：
The invention provides compounds of Formula I or Formula II: or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
公开/授权文献
- US20170362244A1 PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT 公开/授权日：2017-12-21
信息查询
